 CAMBRIDGE, Mass., Dec. 9, 2020 PRNewswire -- Synlogic, Inc. Nasdaq: SYBX, a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the appointment of Michael Heffernan to its board of directors. We are delighted to welcome Mike... 